oncology
GI Cancer

PBS listings for kidney, liver and bladder cancer drugs

Three medications for bladder, liver and renal cancers will be listed on the PBS from 1 March. The anti-PD-1 immunotherapy pembrolizumab (Keytruda) will become available for patients with locally advanced or metastatic urothelial cancer, the government has announced. More than 430 patients a year are expected to be eligible for treatment with pembrolizumab as monotherapy for the ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic